Company Overview of PeriCor Therapeutics, Inc.
PeriCor Therapeutics, Inc., a specialty biopharmaceutical company, develops and commercializes novel therapies to protect threatened heart muscle in surgical and acute settings. It develops adenosine regulating agents, which amplifies the body’s own protective response to ischemia, and reperfusion injury and tissue damage that occurs after interrupted blood flow is restored. PeriCor Therapeutics, Inc. was incorporated in 2004 and is based in New York, New York.
350 Fifth Avenue
New York, NY 10118
Founded in 2004
Key Executives for PeriCor Therapeutics, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact PeriCor Therapeutics, Inc., please visit www.pericortherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.